The average price target is $18.38, with a high forecast of $28.00 and a low forecast of $14.00. In order for the stock price to hit the forecast high, the stock would need to surge +148.23% from its current level, while the stock would need to crash 24.11% from its current level to reach the projected low. HC Wainwright is very positive to TRIL and gave it a "Buy" rating on November 18, 2020. Trillium Therapeutics stock forecast. Real time Trillium Therapeutics (TRIL) stock price quote, stock graph, news & analysis. Trillium Therapeutics Inc. Stock Forecast NASDAQ:TRIL Price Target and Analyst Ratings. Find the latest Earnings Report Date for Trillium Therapeutics Inc. Common Shares (TRIL) at Nasdaq.com. Post-Market 0.01 (0.09%) Trillium Therapeutics Inc has risen higher in 7 of those 16 years over the subsequent 52 week period, corresponding to a historical accuracy of 43.75 % Trillium Therapeutics's share price could reach $19.00 by Dec 8, 2021. This price target is based on 5 analysts offering 12 month price targets for Trillium Therapeutics in the last 3 months. Historical Ratings. Furthermore, Trillium Therapeutics Inc. (TRIL)’s beta value is 0, and its average true range (ATR) is 1.12. Trillium Therapeutics Inc. (TRIL) shares are trading at higher $14.57 and the avg recommendation for the stock is Strong Buy, while the current analyst price target stands at $11.02. Over the next 52 weeks, Trillium Therapeutics Inc has on average historically risen by 60.4 % based on the past 16 years of stock performance. The price target was set to $16.50 → $22.00. The average price target represents a 22.75% upside from the last price of $14.97. Most Recent Rating. The company’s stock has been forecasted to trade at an average price of $22 over the course of the next 52 weeks, with a low of $14 and a high of $28. Trillium Therapeutics Inc Stock Forecast. Trillium Therapeutics Inc. (TRIL) projections and forecasts Over the last 52 weeks, […] Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. A high-level overview of Trillium Therapeutics Inc. (TRIL) stock. TRIL 11.09 0.94 (7.81%). On average, Wall Street analysts predict that . Date Rating Action Authority Three analysts forecast the average price in 12 months at $15.00 with a high forecast of $15.00 and a low forecast of $15.00. Trillium Therapeutics NASDAQ Updated Mar 15, 2021 11:59 PM. Trillium Therapeutics Inc Stock Price Forecast, "TRIL" Predictons for2021 To add more color to this target, the company’s high over the last year is $16.89 and the low is $0.24. The average Trillium Therapeutics stock price prediction forecasts a potential upside of 41.26% from the current TRIL share price of $13.45. Last 30 Days.